Clinical Use of Rivaroxaban: Pharmacokinetic and Pharmacodynamic Rationale for Dosing Regimens in Different Indications (vol 74, pg 1587, 2014)

被引：0
|
作者：
Trujillo, Toby [1 ]
Dobesh, Paul P. [2 ]
机构：
[1] Univ Colorado, Skaggs Sch Pharm & Pharmaceut Sci, Aurora, CO 80045 USA
[2] Univ Nebraska Med Ctr, Coll Pharm, Omaha, NE USA
来源：
DRUGS | 2014年 / 74卷 / 15期
关键词：
D O I：
10.1007/s40265-014-0311-8
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：1837 / 1837
页数：1
相关论文
共 8 条
  • [1] Clinical Use of Rivaroxaban: Pharmacokinetic and Pharmacodynamic Rationale for Dosing Regimens in Different Indications
    Trujillo, Toby
    Dobesh, Paul P.
    [J]. DRUGS, 2014, 74 (14) : 1587 - 1603
  • [2] Clinical Use of Rivaroxaban: Pharmacokinetic and Pharmacodynamic Rationale for Dosing Regimens in Different Indications
    Toby Trujillo
    Paul P. Dobesh
    [J]. Drugs, 2014, 74 : 1587 - 1603
  • [3] Erratum to: Clinical Use of Rivaroxaban: Pharmacokinetic and Pharmacodynamic Rationale for Dosing Regimens in Different Indications
    Toby Trujillo
    Paul P. Dobesh
    [J]. Drugs, 2014, 74 : 1837 - 1837
  • [4] Pharmacodynamic and pharmacokinetic features of cabergoline: rationale for use in Parkinson's disease. (vol 55, pg 10, 1998)
    Fariello, RG
    [J]. DRUGS, 2001, 61 (02) : 196 - 196
  • [5] Use of translational pharmacodynamic biomarkers in early-phase clinical studies for schizophrenia (vol 8, pg 29, 2014)
    English, Brett A.
    [J]. BIOMARKERS IN MEDICINE, 2014, 8 (02) : 309 - 310
  • [6] Sevoflurance: A review of its pharmacodynamic and pharmacokinetic properties and its clinical use in general anaesthesia (vol 51, pg 660, 1996)
    Patel, SS
    Goa, KL
    [J]. DRUGS, 1996, 52 (02) : 253 - 253
  • [7] Efficacy of Super-Bioavailable Itraconazole and Conventional Itraconazole at Different Dosing Regimens in Glabrous Tinea Infection - A Randomized Clinical Trial (vol 17, pg 2899, 2023)
    Shenoy, Manjunath M.
    De, Abhishek
    Shah, Bela
    Das, Anupam
    Saraswat, Abir
    Lahiri, Koushik
    Yadav, Sheetal
    Sarda, Aarti
    Chakraborty, Disha
    Dharmender, J.
    Kamat, Shruti
    Doshi, Yashika
    Gonsalves, Nelry
    Choudhary, Ankita
    Dhoot, Dhiraj
    Mahadkar, Namrata
    Bhushan, Sumit
    Gadkari, Rujuta
    Barkate, Hanmant
    [J]. DRUG DESIGN DEVELOPMENT AND THERAPY, 2023, 17 : 3033 - 3033
  • [8] ARISE-a prospective, non-interventional, single-arm study assessing clinical parameters associated with the use of insulin degludec/insulin aspart in patients with type 2 diabetes in realworld settings: rationale and design (vol 74, pg 530, 2021)
    Fulcher, Gregory R.
    Jarlov, Henrik
    Piltoft, Johanne Spanggaard
    Singh, Kiran Pal
    Liu, Lei
    Mohamed, Mafauzy
    Nicodemus, Nemencio Almare, Jr.
    Al-Jaser, Saleh Jaser
    Kok, Adri
    [J]. ENDOCRINE, 2022, 75 (03) : 964 - 964
1